Active Ingredient History
Nevirapine is a non-nucleoside reverse transcriptase inhibitor (nNRTI) with activity against Human Immunodeficiency Virus Type 1 (HIV-1). HIV-2 RT and eukaryotic DNA polymerases (such as human DNA polymerases alpha, beta, or sigma) are not inhibited by nevirapine. Nevirapine is, in general, only prescribed after the immune system has declined and infections have become evident. It is always taken with at least one other HIV medication such as Retrovir or Videx. The virus can develop resistance to nevirapine if the drug is taken alone, although even if used properly, nevirapine is effective for only a limited time. Nevirapine binds directly to reverse transcriptase (RT) and blocks the RNA-dependent and DNA-dependent DNA polymerase activities by causing a disruption of the enzyme's catalytic site. The activity of nevirapine does not compete with template or nucleoside triphosphates. Nevirapine is used for use in combination with other antiretroviral drugs in the ongoing treatment of HIV-1 infection. NCATS
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Combination drugs
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Acquired Immunodeficiency Syndrome (Phase 4)
Alveolar Bone Loss (Phase 4)
Antigens, CD (Phase 3)
Antiretroviral Therapy, Highly Active (Phase 4)
Cardiovascular Diseases (Phase 4)
Central Nervous System Diseases (Phase 4)
Contraception (Phase 2)
Dementia (Phase 4)
Diabetes Mellitus (Phase 4)
Drugs, Investigational (Phase 4)
Healthy Volunteers (Phase 1)
Hepatic Insufficiency (Phase 4)
Herpesvirus 8, Human (Phase 4)
HIV (Phase 4)
HIV-1 (Phase 4)
HIV-Associated Lipodystrophy Syndrome (Phase 4)
HIV Seropositivity (Phase 2)
Hypercholesterolemia (Phase 4)
Insulin Resistance (Phase 4)
Lipodystrophy (Phase 2)
Liver Diseases (Phase 4)
Malaria (Phase 3)
Metabolism (Phase 4)
Parasitic Diseases (Phase 1/Phase 2)
Pregnancy (Phase 3)
Quality of Life (Phase 4)
Renal Insufficiency (Phase 1)
Sarcoma, Kaposi (Phase 4)
Tuberculosis (Phase 4)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue